100 years of suramin

N Wiedemar, DA Hauser, P Mäser - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Suramin is 100 years old and is still being used to treat the first stage of acute human
sleeping sickness, caused by Trypanosoma brucei rhodesiense. Suramin is a …

Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum

Y Manickam, R Chaturvedi, P Babbar, N Malhotra… - Drug discovery today, 2018 - Elsevier
Highlights•Malaria remains a killer disease and drug resistance poses a growing
problem.•Aminoacyl tRNA synthetases (aaRSs) are essential housekeeping …

In silico Structure Prediction, Molecular Docking, and Dynamic Simulation of Plasmodium falciparum AP2-I Transcription Factor

DO Oladejo, GO Oduselu… - … and Biology Insights, 2023 - journals.sagepub.com
Plasmodium falciparum Apicomplexan Apetala 2 Invasion (Pf AP2-I) transcription factor (TF)
is a protein that regulates the expression of a subset of gene families involved in P …

Aminoacyl tRNA synthetases as malarial drug targets: a comparative bioinformatics study

DW Nyamai, Ö Tastan Bishop - Malaria journal, 2019 - Springer
Background Treatment of parasitic diseases has been challenging due to evolution of drug
resistant parasites, and thus there is need to identify new class of drugs and drug targets …

Analysing the essential proteins set of Plasmodium falciparum PF3D7 for novel drug targets identification against malaria

F Ali, H Wali, S Jan, A Zia, M Aslam, I Ahmad, SG Afridi… - Malaria journal, 2021 - Springer
Background Plasmodium falciparum is an obligate intracellular parasite of humans that
causes malaria. Falciparum malaria is a major public health threat to human life responsible …

Structural analyses of the malaria parasite aminoacyl‐tRNA synthetases provide new avenues for antimalarial drug discovery

J Chhibber‐Goel, M Yogavel, A Sharma - Protein Science, 2021 - Wiley Online Library
Malaria is a parasitic illness caused by the genus Plasmodium from the apicomplexan
phylum. Five plasmodial species of P. falciparum (Pf), P. knowlesi, P. malariae, P. ovale, and …

Repurposing drugs to fight hepatic malaria parasites

D Fontinha, I Moules, M Prudêncio - Molecules, 2020 - mdpi.com
Malaria remains one of the most prevalent infectious diseases worldwide, primarily affecting
some of the most vulnerable populations around the globe. Despite achievements in the …

Proposition of In silico Pharmacophore Models for Malaria: A Review

NF de Sousa, IMA de Araújo… - … Chemistry & High …, 2024 - benthamdirect.com
In the field of medicinal chemistry, the concept of pharmacophore refers to the specific
region of a molecule that possesses essential structural and chemical characteristics for …

Recent advances in the biology and drug targeting of malaria parasite aminoacyl-tRNA synthetases

S Khan - Malaria journal, 2016 - Springer
Escalating drug resistance in malaria parasites and lack of vaccine entails the discovery of
novel drug targets and inhibitor molecules. The multi-component protein translation …

Synthesis, in silico and in vitro antimicrobial efficacy of substituted arylidene-based quinazolin-4(3H)-one motifs

GO Oduselu, DV Aderohunmu, OO Ajani… - Frontiers in …, 2023 - frontiersin.org
Introduction: Quinazolin-4 (3 H)-one derivatives have attracted considerable attention in the
pharmacological profiling of therapeutic drug targets. The present article reveals the …